2017
DOI: 10.1016/j.neuropharm.2017.09.014
|View full text |Cite
|
Sign up to set email alerts
|

Maslinic acid ameliorates NMDA receptor blockade-induced schizophrenia-like behaviors in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
14
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(16 citation statements)
references
References 64 publications
2
14
0
Order By: Relevance
“…Unfortunately, the anatomy of naked mole rats, and specifically the location of large muscle masses on the top of the cranium, which are critical for eating, digging, and other social functions within the colony, makes stereotaxic implantation of permanent cannulas that target the respiratory brainstem detrimental to the health and sociability of this species. However, intraperitoneal injections of these same pharmacological agents have been used previously in numerous studies in mice and rats to evaluate a wide variety of physiological and behavioral responses (for example: Velisek et al, 1995; Mead and Stephens, 1999; Berrino et al, 2003; Murschall and Hauber, 2005; Reid and Powell, 2005; McGuire et al, 2008; Jeon et al, 2017; Xiang et al, 2018). This large body of literature in which these drugs impacted physiological function following intraperitoneal injection (as in our study) indicates that these agents successfully cross the blood brain barrier to interact with AMPARs and NMDARs, which are not found outside of the CNS.…”
Section: Discussionmentioning
confidence: 99%
“…Unfortunately, the anatomy of naked mole rats, and specifically the location of large muscle masses on the top of the cranium, which are critical for eating, digging, and other social functions within the colony, makes stereotaxic implantation of permanent cannulas that target the respiratory brainstem detrimental to the health and sociability of this species. However, intraperitoneal injections of these same pharmacological agents have been used previously in numerous studies in mice and rats to evaluate a wide variety of physiological and behavioral responses (for example: Velisek et al, 1995; Mead and Stephens, 1999; Berrino et al, 2003; Murschall and Hauber, 2005; Reid and Powell, 2005; McGuire et al, 2008; Jeon et al, 2017; Xiang et al, 2018). This large body of literature in which these drugs impacted physiological function following intraperitoneal injection (as in our study) indicates that these agents successfully cross the blood brain barrier to interact with AMPARs and NMDARs, which are not found outside of the CNS.…”
Section: Discussionmentioning
confidence: 99%
“…It has been well-established that NMDAR play a key role in the etiology and pharmacological treatments of schizophrenia ( Gilmour et al, 2012 ; Jadi et al, 2016 ; Dauvermann et al, 2017 ; Jeon et al, 2017 ). For instance, a considerable amount of research has demonstrated that NMDAR antagonists mimic psychosis-relevant behaviors and deficits in sensory gating ( Jeon et al, 2017 ; Oh et al, 2017 ). Based on this hypothesis, the current study evaluated the involvement of NMDAR subunits in the symptoms of schizophrenia in mice induced by the repeated administration of the NMDAR antagonist MK-801.…”
Section: Discussionmentioning
confidence: 99%
“…NMDAR plays a key role in the etiology and drug treatment of SZ (Lee and Zhou, 2019). Numerous studies have confirmed that NMDAR antagonists induce SZ-related behavior (Jeon et al, 2017). Meanwhile, our previous studies (Ding et al, 2017(Ding et al, , 2019 and other work (Seillier and Giuffrida, 2009;Jacklin et al, 2012;Karamihalev et al, 2014;Li et al, 2016) found cognition impairment and alterations in anatomical and neurochemical aspects in a mouse subchronic model of SZ induced by the intraperitoneal injection of MK-801 for 14 consecutive days.…”
Section: Discussionmentioning
confidence: 85%